1
|
Abstract
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications.
Collapse
Affiliation(s)
- Kylie N Barnes
- Kansas City School of Pharmacy, University of Missouri, Kansas City, MO, USA
| | - Lauren D Leader
- Obstetrics and Gynecology, Von Voigtlander Women's Hospital, Michigan Medicine, Ann Arbor, MI, USA
| | - Nicole E Cieri-Hutcherson
- Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA
| | | | - Mary F Hebert
- Obstetrics and Gynecology, University of Washington, Seattle, WA, USA
| | - Lamis R Karaoui
- Department of Pharmacy Practice, Lebanese American University School of Pharmacy, Byblos, Lebanon
| | - Sarah McBane
- School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, USA
| |
Collapse
|
2
|
Bernauer JC, Schmidt A, Henderson BS, Ice LD, Khaneft D, O'Connor C, Russell R, Akopov N, Alarcon R, Ates O, Avetisyan A, Beck R, Belostotski S, Bessuille J, Brinker F, Calarco JR, Carassiti V, Cisbani E, Ciullo G, Contalbrigo M, De Leo R, Diefenbach J, Donnelly TW, Dow K, Elbakian G, Eversheim PD, Frullani S, Funke C, Gavrilov G, Gläser B, Görrissen N, Hasell DK, Hauschildt J, Hoffmeister P, Holler Y, Ihloff E, Izotov A, Kaiser R, Karyan G, Kelsey J, Kiselev A, Klassen P, Krivshich A, Kohl M, Lehmann I, Lenisa P, Lenz D, Lumsden S, Ma Y, Maas F, Marukyan H, Miklukho O, Milner RG, Movsisyan A, Murray M, Naryshkin Y, Perez Benito R, Perrino R, Redwine RP, Rodríguez Piñeiro D, Rosner G, Schneekloth U, Seitz B, Statera M, Thiel A, Vardanyan H, Veretennikov D, Vidal C, Winnebeck A, Yeganov V. Measurement of the Charge-Averaged Elastic Lepton-Proton Scattering Cross Section by the OLYMPUS Experiment. Phys Rev Lett 2021; 126:162501. [PMID: 33961478 DOI: 10.1103/physrevlett.126.162501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 03/17/2021] [Accepted: 03/23/2021] [Indexed: 06/12/2023]
Abstract
We report the first measurement of the average of the electron-proton and positron-proton elastic scattering cross sections. This lepton charge-averaged cross section is insensitive to the leading effects of hard two-photon exchange, giving more robust access to the proton's electromagnetic form factors. The cross section was extracted from data taken by the OLYMPUS experiment at DESY, in which alternating stored electron and positron beams were scattered from a windowless gaseous hydrogen target. Elastic scattering events were identified from the coincident detection of the scattered lepton and recoil proton in a large-acceptance toroidal spectrometer. The luminosity was determined from the rates of Møller, Bhabha, and elastic scattering in forward electromagnetic calorimeters. The data provide some selectivity between existing form factor global fits and will provide valuable constraints to future fits.
Collapse
Affiliation(s)
- J C Bernauer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Schmidt
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - B S Henderson
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - L D Ice
- Arizona State University, Tempe, Arizona 85287, USA
| | - D Khaneft
- Johannes Gutenberg-Universität, Mainz, Germany
| | - C O'Connor
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Russell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - N Akopov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - R Alarcon
- Arizona State University, Tempe, Arizona 85287, USA
| | - O Ates
- Hampton University, Hampton, Virginia 23668, USA
| | - A Avetisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - R Beck
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - S Belostotski
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - J Bessuille
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - F Brinker
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - J R Calarco
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - V Carassiti
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - E Cisbani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, Rome, Italy
| | - G Ciullo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - M Contalbrigo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - R De Leo
- Istituto Nazionale di Fisica Nucleare sezione di Bari, Bari, Italy
| | - J Diefenbach
- Hampton University, Hampton, Virginia 23668, USA
| | - T W Donnelly
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K Dow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Elbakian
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - P D Eversheim
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - S Frullani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, Rome, Italy
| | - Ch Funke
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - G Gavrilov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - B Gläser
- Johannes Gutenberg-Universität, Mainz, Germany
| | - N Görrissen
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - D K Hasell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Hauschildt
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - Ph Hoffmeister
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - Y Holler
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - E Ihloff
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Izotov
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - R Kaiser
- University of Glasgow, Glasgow, United Kingdom
| | - G Karyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - J Kelsey
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Kiselev
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - P Klassen
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - A Krivshich
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - M Kohl
- Hampton University, Hampton, Virginia 23668, USA
| | - I Lehmann
- University of Glasgow, Glasgow, United Kingdom
| | - P Lenisa
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - D Lenz
- Deutsches Elektronen-Synchrotron, Hamburg, Germany
| | - S Lumsden
- University of Glasgow, Glasgow, United Kingdom
| | - Y Ma
- Johannes Gutenberg-Universität, Mainz, Germany
| | - F Maas
- Johannes Gutenberg-Universität, Mainz, Germany
| | - H Marukyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | - O Miklukho
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Movsisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - M Murray
- University of Glasgow, Glasgow, United Kingdom
| | - Y Naryshkin
- Petersburg Nuclear Physics Institute, Gatchina, Russia
| | | | - R Perrino
- Istituto Nazionale di Fisica Nucleare sezione di Bari, Bari, Italy
| | - R P Redwine
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | | | - G Rosner
- University of Glasgow, Glasgow, United Kingdom
| | | | - B Seitz
- University of Glasgow, Glasgow, United Kingdom
| | - M Statera
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, Ferrara, Italy
| | - A Thiel
- Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
| | - H Vardanyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| | | | - C Vidal
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Winnebeck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - V Yeganov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), Yerevan, Armenia
| |
Collapse
|
3
|
Leung K, Ahmed M, Alarcon R, Aleksandrova A, Baeßler S, Barrón-Palos L, Bartoszek L, Beck D, Behzadipour M, Bessuille J, Blatnik M, Broering M, Broussard L, Busch M, Carr R, Chu PH, Cianciolo V, Clayton S, Cooper M, Crawford C, Currie S, Daurer C, Dipert R, Dow K, Dutta D, Efremenko Y, Erickson C, Filippone B, Fomin N, Gao H, Golub R, Gould C, Greene G, Haase D, Hasell D, Hawari A, Hayden M, Holley A, Holt R, Huffman P, Ihloff E, Ito T, Kelsey J, Kim Y, Korobkina E, Korsch W, Lamoreaux S, Leggett E, Lipman A, Liu CY, Long J, MacDonald S, Makela M, Matlashov A, Maxwell J, McCrea M, Mendenhall M, Meyer H, Milner R, Mueller P, Nouri N, O'Shaughnessy C, Osthelder C, Peng JC, Penttila S, Phan N, Plaster B, Ramsey J, Rao T, Redwine R, Reid A, Saftah A, Seidel G, Silvera I, Slutsky S, Smith E, Snow W, Sondheim W, Sosothikul S, Stanislaus T, Sun X, Swank C, Tang Z, Dinani RT, Tsentalovich E, Vidal C, Wei W, White C, Williamson S, Yang L, Yao W, Young A. The neutron electric dipole moment experiment at the Spallation Neutron Source. EPJ Web Conf 2019. [DOI: 10.1051/epjconf/201921902005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Novel experimental techniques are required to make the next big leap in neutron electric dipole moment experimental sensitivity, both in terms of statistics and systematic error control. The nEDM experiment at the Spallation Neutron Source (nEDM@SNS) will implement the scheme of Golub & Lamoreaux [Phys. Rep., 237, 1 (1994)]. The unique properties of combining polarized ultracold neutrons, polarized 3He, and superfluid 4He will be exploited to provide a sensitivity to ∼ 10−28 e · cm. Our cryogenic apparatus will deploy two small (3 L) measurement cells with a high density of ultracold neutrons produced and spin analyzed in situ. The electric field strength, precession time, magnetic shielding, and detected UCN number will all be enhanced compared to previous room temperature Ramsey measurements. Our 3He co-magnetometer offers unique control of systematic effects, in particular the Bloch-Siegert induced false EDM. Furthermore, there will be two distinct measurement modes: free precession and dressed spin. This will provide an important self-check of our results. Following five years of “critical component demonstration,” our collaboration transitioned to a “large scale integration” phase in 2018. An overview of our measurement techniques, experimental design, and brief updates are described in these proceedings.
Collapse
|
4
|
Triolo TM, Fouts A, Pyle L, Yu L, Gottlieb PA, Steck AK, Greenbaum CJ, Atkinson M, Baidal D, Battaglia M, Becker D, Bingley P, Bosi E, Buckner J, Clements M, Colman P, DiMeglio L, Gitelman S, Goland R, Gottlieb P, Herold K, Knip M, Krischer J, Lernmark A, Moore W, Moran A, Muir A, Palmer J, Peakman M, Philipson L, Raskin P, Redondo M, Rodriguez H, Russell W, Spain L, Schatz D, Sosenko J, Wentworth J, Wherrett D, Wilson D, Winter W, Ziegler A, Anderson M, Antinozzi P, Benoist C, Blum J, Bourcier K, Chase P, Clare-Salzler M, Clynes R, Eisenbarth G, Fathman C, Grave G, Hering B, Insel R, Kaufman F, Kay T, Leschek E, Mahon J, Marks J, Nanto-Salonen K, Nepom G, Orban T, Parkman R, Pescovitz M, Peyman J, Pugliese A, Roep B, Roncarolo M, Savage P, Simell O, Sherwin R, Siegelman M, Skyler J, Steck A, Thomas J, Trucco M, Wagner J, Krischer JP, Leschek E, Rafkin L, Bourcier K, Cowie C, Foulkes M, Insel R, Krause-Steinrauf H, Lachin JM, Malozowski S, Peyman J, Ridge J, Savage P, Skyler JS, Zafonte SJ, Rafkin L, Sosenko JM, Kenyon NS, Santiago I, Krischer JP, Bundy B, Abbondondolo M, Dixit S, Pasha M, King K, Adcock H, Atterberry L, Fox K, Englert N, Mauras J, Permuy K, Sikes T, Adams T, Berhe B, Guendling L, McLennan L, Paganessi C, Murphy M, Draznin M, Kamboj S, Sheppard V, Lewis L, Coates W, Amado D, Moore G, Babar J, Bedard D, Brenson-Hughes J, Cernich M, Clements R, Duprau S, Goodman L, Hester L, Huerta-Saenz A, Asif I, Karmazin T, Letjen S, Raman D, Morin W, Bestermann E, Morawski J, White A, Brockmyer R, Bays S, Campbell A, Boonstra M, Stapleton N, Stone A, Donoho H, Everett H, Hensley M, Johnson C, Marshall N, Skirvin P, Taylor R, Williams L, Burroughs C, Ray C, Wolverton D, Nickels C, Dothard P, Speiser M, Pellizzari L, Bokor K, Izuora S, Abdelnour P, Cummings S, Cuthbertson D, Paynor M, Leahy M, Riedl S, Shockley R, Saad T, Briones S, Casella C, Herz K, Walsh J, Greening F, Deemer M, Hay S, Hunt N, Sikotra L, Simons D, Karounos R, Oremus L, Dye L, Myers D, Ballard W, Miers R, Eberhard C, Sparks K, Thraikill K, Edwards J, Fowlkes S, Kemp A, Morales L, Holland L, Johnson P, Paul A, Ghatak K, Fiske S, Phelen H, Leyland T, Henderson D, Brenner E, Oppenheimer I, Mamkin C, Moniz C, Clarson M, Lovell A, Peters V, Ford J, Ruelas D, Borut D, Burt M, Jordan S, Castilla P, Flores M, Ruiz L, Hanson J, Green-Blair R, Sheridan K, Garmeson J, Wintergerst G, Pierce A, Omoruyi M, Foster S, Kingery A, Lunsford I, Cervantes T, Parker P, Price J, Urben I, Guillette H, Doughty H, Haydock V, Parker P, Bergman S, Duncum C, Rodda A, Perelman R, Calendo C, Barrera E, Arce-Nunez Y, Geyer S, Martinez M, De la Portilla I, Cardenas L, Garrido M, Villar R, Lorini E, Calandra G, D’Annuzio K, Perri N, Minuto C, Hays B, Rebora R, Callegari O, Ali J, Kramer B, Auble S, Cabrera P, Donohoue R, Fiallo-Scharer M, Hessner P, Wolfgram A, Henderson C, Kansra N, Bettin R, McCuller A, Miller S, Accacha J, Corrigan E, Fiore R, Levine T, Mahoney C, Polychronakos V, Henry M, Gagne H, Starkman M, Fox D, Chin F, Melchionne L, Silverman I, Marshall L, Cerracchio J, Cruz A, Viswanathan J, Heyman K, Wilson S, Chalew S, Valley S, Layburn A, Lala P, Clesi M, Genet G, Uwaifo A, Charron T, Allerton W, Hsiao B, Cefalu L, Melendez-Ramirez R, Richards C, Alleyn E, Gustafson M, Lizanna J, Wahlen S, Aleiwe M, Hansen H, Wahlen C, Karges C, Levy A, Bonaccorso R, Rapaport Y, Tomer D, Chia M, Goldis L, Iazzetti M, Klein C, Levister L, Waldman E, Keaton N, Wallach M, Regelmann Z, Antal M, Aranda C, Reynholds A, Vinik P, Barlow M, Bourcier M, Nevoret J, Couper S, Kinderman A, Beresford N, Thalagne H, Roper J, Gibbons J, Hill S, Balleaut C, Brennan J, Ellis-Gage L, Fear T, Gray L, Law P, Jones C, McNerney L, Pointer N, Price K, Few D, Tomlinson N, Leech D, Wake C, Owens M, Burns J, Leinbach A, Wotherspoon A, Murray K, Short G, Curry S, Kelsey J, Lawson J, Porter S, Stevens E, Thomson S, Winship L, Liu S, Wynn E, Wiltshire J, Krebs P, Cresswell H, Faherty C, Ross L, Denvir J, Drew T, Randell P, Mansell S, Lloyd J, Bell S, Butler Y, Hooton H, Navarra A, Roper G, Babington L, Crate H, Cripps A, Ledlie C, Moulds R, Malloy J, Norton B, Petrova O, Silkstone C, Smith K, Ghai M, Murray V, Viswanathan M, Henegan O, Kawadry J, Olson L, Maddox K, Patterson T, Ahmad B, Flores D, Domek S, Domek K, Copeland M, George J, Less T, Davis M, Short A, Martin J, Dwarakanathan P, O’Donnell B, Boerner L, Larson M, Phillips M, Rendell K, Larson C, Smith K, Zebrowski L, Kuechenmeister M, Miller J, Thevarayapillai M, Daniels H, Speer N, Forghani R, Quintana C, Reh A, Bhangoo P, Desrosiers L, Ireland T, Misla C, Milliot E, Torres S, Wells J, Villar M, Yu D, Berry D, Cook J, Soder A, Powell M, Ng M, Morrison Z, Moore M, Haslam M, Lawson B, Bradley J, Courtney C, Richardson C, Watson E, Keely D, DeCurtis M, Vaccarcello-Cruz Z, Torres K, Muller S, Sandberg H, Hsiang B, Joy D, McCormick A, Powell H, Jones J, Bell S, Hargadon S, Hudson M, Kummer S, Nguyen T, Sauder E, Sutton K, Gensel R, Aguirre-Castaneda V, Benavides, Lopez D, Hemp S, Allen J, Stear E, Davis T, O’Donnell R, Jones A, Roberts J, Dart N, Paramalingam L, Levitt Katz N, Chaudhary K, Murphy S, Willi B, Schwartzman C, Kapadia D, Roberts A, Larson D, McClellan G, Shaibai L, Kelley G, Villa C, Kelley R, Diamond M, Kabbani T, Dajani F, Hoekstra M, Sadler K, Magorno J, Holst V, Chauhan N, Wilson P, Bononi M, Sperl A, Millward M, Eaton L, Dean J, Olshan H, Stavros T, Renna C, Milliard, Brodksy L, Bacon J, Quintos L, Topor S, Bialo B, Bancroft A, Soto W, Lagarde H, Tamura R, Lockemer T, Vanderploeg M, Ibrahim M, Huie V, Sanchez R, Edelen R, Marchiando J, Palmer T, Repas M, Wasson P, Wood K, Auker J, Culbertson T, Kieffer D, Voorhees T, Borgwardt L, DeRaad K, Eckert E, Isaacson H, Kuhn A, Carroll M, Xu P, Schubert G, Francis S, Hagan T, Le M, Penn E, Wickham C, Leyva K, Rivera J, Padilla I, Rodriguez N, Young K, Jospe J, Czyzyk B, Johnson U, Nadgir N, Marlen G, Prakasam C, Rieger N, Glaser E, Heiser B, Harris C, Alies P, Foster H, Slater K, Wheeler D, Donaldson M, Murray D, Hale R, Tragus D, Word J, Lynch L, Pankratz W, Badias F, Rogers R, Newfield S, Holland M, Hashiguchi M, Gottschalk A, Philis-Tsimikas R, Rosal S, Franklin S, Guardado N, Bohannon M, Baker A, Garcia T, Aguinaldo J, Phan V, Barraza D, Cohen J, Pinsker U, Khan J, Wiley L, Jovanovic P, Misra M, Bassi M, Wright D, Cohen K, Huang M, Skiles S, Maxcy C, Pihoker K, Cochrane J, Fosse S, Kearns M, Klingsheim N, Beam C, Wright L, Viles H, Smith S, Heller M, Cunningham A, Daniels L, Zeiden J, Field R, Walker K, Griffin L, Boulware D, Bartholow C, Erickson J, Howard B, Krabbenhoft C, Sandman A, Vanveldhuizen J, Wurlger A, Zimmerman K, Hanisch L, Davis-Keppen A, Bounmananh L, Cotterill J, Kirby M, Harris A, Schmidt C, Kishiyama C, Flores J, Milton W, Martin C, Whysham A, Yerka T, Bream S, Freels J, Hassing J, Webster R, Green P, Carter J, Galloway D, Hoelzer S, Roberts S, Said P, Sullivan H, Freeman D, Allen E, Reiter E, Feinberg C, Johnson L, Newhook D, Hagerty N, White L, Levandoski J, Kyllo M, Johnson C, Gough J, Benoit P, Iyer F, Diamond H, Hosono S, Jackman L, Barette P, Jones I, Sills S, Bzdick J, Bulger R, Ginem J, Weinstock I, Douek R, Andrews G, Modgill G, Gyorffy L, Robin N, Vaidya S, Crouch K, O’Brien C, Thompson N, Granger M, Thorne J, Blumer J, Kalic L, Klepek J, Paulett B, Rosolowski J, Horner M, Watkins J, Casey K, Carpenter C, Michelle Kieffer MH, Burns J, Horton C, Pritchard D, Soetaert A, Wynne C, Chin O, Molina C, Patel R, Senguttuvan M, Wheeler O, Lane P, Furet C, Steuhm D, Jelley S, Goudeau L, Chalmers D, Greer C, Panagiotopoulos D, Metzger D, Nguyen M, Horowitz M, Linton C, Christiansen E, Glades C, Morimoto M, Macarewich R, Norman K, Patin C, Vargas A, Barbanica A, Yu P, Vaidyanathan W, Nallamshetty L, Osborne R, Mehra S, Kaster S, Neace J, Horner G, Reeves C, Cordrey L, Marrs T, Miller S, Dowshen D, Oduah V, Doyle S, Walker D, Catte H, Dean M, Drury-Brown B, Hackman M, Lee S, Malkani K, Cullen K, Johnson P, Parrimon Y, Hampton M, McCarrell C, Curtis E, Paul, Zambrano Y, Paulus K, Pilger J, Ramiro J, Luvon Ritzie AQ, Sharma A, Shor A, Song X, Terry A, Weinberger J, Wootten M, Lachin JM, Foulkes M, Harding P, Krause-Steinrauf H, McDonough S, McGee PF, Owens Hess K, Phoebus D, Quinlan S, Raiden E, Batts E, Buddy C, Kirpatrick K, Ramey M, Shultz A, Webb C, Romesco M, Fradkin J, Leschek E, Spain L, Savage P, Aas S, Blumberg E, Beck G, Brillon D, Gubitosi-Klug R, Laffel L, Vigersky R, Wallace D, Braun J, Lernmark A, Lo B, Mitchell H, Naji A, Nerup J, Orchard T, Steffes M, Tsiatis A, Veatch R, Zinman B, Loechelt B, Baden L, Green M, Weinberg A, Marcovina S, Palmer JP, Weinberg A, Yu L, Babu S, Winter W, Eisenbarth GS, Bingley P, Clynes R, DiMeglio L, Eisenbarth G, Hays B, Leschek E, Marks J, Matheson D, Rafkin L, Rodriguez H, Spain L, Wilson D, Redondo M, Gomez D, McDonald A, Pena S, Pietropaolo M, Shippy K, Batts E, Brown T, Buckner J, Dove A, Hammond M, Hefty D, Klein J, Kuhns K, Letlau M, Lord S, McCulloch-Olson M, Miller L, Nepom G, Odegard J, Ramey M, Sachter E, St. Marie M, Stickney K, VanBuecken D, Vellek B, Webber C, Allen L, Bollyk J, Hilderman N, Ismail H, Lamola S, Sanda S, Vendettuoli H, Tridgell D, Monzavi R, Bock M, Fisher L, Halvorson M, Jeandron D, Kim M, Wood J, Geffner M, Kaufman F, Parkman R, Salazar C, Goland R, Clynes R, Cook S, Freeby M, Pat Gallagher M, Gandica R, Greenberg E, Kurland A, Pollak S, Wolk A, Chan M, Koplimae L, Levine E, Smith K, Trast J, DiMeglio L, Blum J, Evans-Molina C, Hufferd R, Jagielo B, Kruse C, Patrick V, Rigby M, Spall M, Swinney K, Terrell J, Christner L, Ford L, Lynch S, Menendez M, Merrill P, Pescovitz M, Rodriguez H, Alleyn C, Baidal D, Fay S, Gaglia J, Resnick B, Szubowicz S, Weir G, Benjamin R, Conboy D, deManbey A, Jackson R, Jalahej H, Orban T, Ricker A, Wolfsdorf J, Zhang HH, Wilson D, Aye T, Baker B, Barahona K, Buckingham B, Esrey K, Esrey T, Fathman G, Snyder R, Aneja B, Chatav M, Espinoza O, Frank E, Liu J, Perry J, Pyle R, Rigby A, Riley K, Soto A, Gitelman S, Adi S, Anderson M, Berhel A, Breen K, Fraser K, Gerard-Gonzalez A, Jossan P, Lustig R, Moassesfar S, Mugg A, Ng D, Prahalod P, Rangel-Lugo M, Sanda S, Tarkoff J, Torok C, Wesch R, Aslan I, Buchanan J, Cordier J, Hamilton C, Hawkins L, Ho T, Jain A, Ko K, Lee T, Phelps S, Rosenthal S, Sahakitrungruang T, Stehl L, Taylor L, Wertz M, Wong J, Philipson L, Briars R, Devine N, Littlejohn E, Grant T, Gottlieb P, Klingensmith G, Steck A, Alkanani A, Bautista K, Bedoy R, Blau A, Burke B, Cory L, Dang M, Fitzgerald-Miller L, Fouts A, Gage V, Garg S, Gesauldo P, Gutin R, Hayes C, Hoffman M, Ketchum K, Logsden-Sackett N, Maahs D, Messer L, Meyers L, Michels A, Peacock S, Rewers M, Rodriguez P, Sepulbeda F, Sippl R, Steck A, Taki I, Tran BK, Tran T, Wadwa RP, Zeitler P, Barker J, Barry S, Birks L, Bomsburger L, Bookert T, Briggs L, Burdick P, Cabrera R, Chase P, Cobry E, Conley A, Cook G, Daniels J, DiDomenico D, Eckert J, Ehler A, Eisenbarth G, Fain P, Fiallo-Scharer R, Frank N, Goettle H, Haarhues M, Harris S, Horton L, Hutton J, Jeffrrey J, Jenison R, Jones K, Kastelic W, King MA, Lehr D, Lungaro J, Mason K, Maurer H, Nguyen L, Proto A, Realsen J, Schmitt K, Schwartz M, Skovgaard S, Smith J, Vanderwel B, Voelmle M, Wagner R, Wallace A, Walravens P, Weiner L, Westerhoff B, Westfall E, Widmer K, Wright H, Schatz D, Abraham A, Atkinson M, Cintron M, Clare-Salzler M, Ferguson J, Haller M, Hosford J, Mancini D, Rohrs H, Silverstein J, Thomas J, Winter W, Cole G, Cook R, Coy R, Hicks E, Lewis N, Marks J, Pugliese A, Blaschke C, Matheson D, Pugliese A, Sanders-Branca N, Ray Arce LA, Cisneros M, Sabbag S, Moran A, Gibson C, Fife B, Hering B, Kwong C, Leschyshyn J, Nathan B, Pappenfus B, Street A, Boes MA, Peterson Eck S, Finney L, Albright Fischer T, Martin A, Jacqueline Muzamhindo C, Rhodes M, Smith J, Wagner J, Wood B, Becker D, Delallo K, Diaz A, Elnyczky B, Libman I, Pasek B, Riley K, Trucco M, Copemen B, Gwynn D, Toledo F, Rodriguez H, Bollepalli S, Diamond F, Eyth E, Henson D, Lenz A, Shulman D, Raskin P, Adhikari S, Dickson B, Dunnigan E, Lingvay I, Pruneda L, Ramos-Roman M, Raskin P, Rhee C, Richard J, Siegelman M, Sturges D, Sumpter K, White P, Alford M, Arthur J, Aviles-Santa ML, Cordova E, Davis R, Fernandez S, Fordan S, Hardin T, Jacobs A, Kaloyanova P, Lukacova-Zib I, Mirfakhraee S, Mohan A, Noto H, Smith O, Torres N, Wherrett D, Balmer D, Eisel L, Kovalakovska R, Mehan M, Sultan F, Ahenkorah B, Cevallos J, Razack N, Jo Ricci M, Rhode A, Srikandarajah M, Steger R, Russell WE, Black M, Brendle F, Brown A, Moore D, Pittel E, Robertson A, Shannon A, Thomas JW, Herold K, Feldman L, Sherwin R, Tamborlane W, Weinzimer S, Toppari J, Kallio T, Kärkkäinen M, Mäntymäki E, Niininen T, Nurmi B, Rajala P, Romo M, Suomenrinne S, Näntö-Salonen K, Simell O, Simell T, Bosi E, Battaglia M, Bianconi E, Bonfanti R, Grogan P, Laurenzi A, Martinenghi S, Meschi F, Pastore M, Falqui L, Teresa Muscato M, Viscardi M, Bingley P, Castleden H, Farthing N, Loud S, Matthews C, McGhee J, Morgan A, Pollitt J, Elliot-Jones R, Wheaton C, Knip M, Siljander H, Suomalainen H, Colman P, Healy F, Mesfin S, Redl L, Wentworth J, Willis J, Farley M, Harrison L, Perry C, Williams F, Mayo A, Paxton J, Thompson V, Volin L, Fenton C, Carr L, Lemon E, Swank M, Luidens M, Salgam M, Sharma V, Schade D, King C, Carano R, Heiden J, Means N, Holman L, Thomas I, Madrigal D, Muth T, Martin C, Plunkett C, Ramm C, Auchus R, Lane W, Avots E, Buford M, Hale C, Hoyle J, Lane B, Muir A, Shuler S, Raviele N, Ivie E, Jenkins M, Lindsley K, Hansen I, Fadoju D, Felner E, Bode B, Hosey R, Sax J, Jefferies C, Mannering S, Prentis R, She J, Stachura M, Hopkins D, Williams J, Steed L, Asatapova E, Nunez S, Knight S, Dixon P, Ching J, Donner T, Longnecker S, Abel K, Arcara K, Blackman S, Clark L, Cooke D, Plotnick L, Levin P, Bromberger L, Klein K, Sadurska K, Allen C, Michaud D, Snodgrass H, Burghen G, Chatha S, Clark C, Silverberg J, Wittmer C, Gardner J, LeBoeuf C, Bell P, McGlore O, Tennet H, Alba N, Carroll M, Baert L, Beaton H, Cordell E, Haynes A, Reed C, Lichter K, McCarthy P, McCarthy S, Monchamp T, Roach J, Manies S, Gunville F, Marosok L, Nelson T, Ackerman K, Rudolph J, Stewart M, McCormick K, May S, Falls T, Barrett T, Dale K, Makusha L, McTernana C, Penny-Thomas K, Sullivan K, Narendran P, Robbie J, Smith D, Christensen R, Koehler B, Royal C, Arthur T, Houser H, Renaldi J, Watsen S, Wu P, Lyons L, House B, Yu J, Holt H, Nation M, Vickers C, Watling R, Heptulla R, Trast J, Agarwal C, Newell D, Katikaneni R, Gardner C, Del A, Rio A, Logan H, Collier C, Rishton G, Whalley A, Ali S, Ramtoola T, Quattrin L, Mastrandea A, House M, Ecker C, Huang C, Gougeon J, Ho D, Pacuad D, Dunger J, May C, O’Brien C, Acerini B, Salgin A, Thankamony R, Williams J, Buse G, Fuller M, Duclos J, Tricome H, Brown D, Pittard D, Bowlby A, Blue T, Headley S, Bendre K, Lewis K, Sutphin C, Soloranzo J, Puskaric H, Madison M, Rincon M, Carlucci R, Shridharani B, Rusk E, Tessman D, Huffman H, Abrams B, Biederman M, Jones V, Leathers W, Brickman P, Petrie D, Zimmerman J, Howard L, Miller R, Alemzadeh D, Mihailescu R, Melgozza-Walker N, Abdulla C, Boucher-Berry D, Ize-Ludlow R, Levy C, Swenson, Brousell N, Crimmins D, Edler T, Weis C, Schultz D, Rogers D, Latham C, Mawhorter C, Switzer W, Spencer P, Konstantnopoulus S, Broder J, Klein L, Knight L, Szadek G, Welnick B, Thompson R, Hoffman A, Revell J, Cherko K, Carter E, Gilson J, Haines G, Arthur B, Bowen W, Zipf P, Graves R, Lozano D, Seiple K, Spicer A, Chang J, Fregosi J, Harbinson C, Paulson S, Stalters P, Wright D, Zlock A, Freeth J, Victory H, Maheshwari A, Maheshwari T, Holmstrom J, Bueno R, Arguello J, Ahern L, Noreika V, Watson S, Hourse P, Breyer C, Kissel Y, Nicholson M, Pfeifer S, Almazan J, Bajaj M, Quinn K, Funk J, McCance E, Moreno R, Veintimilla A, Wells J, Cook S, Trunnel J, Henske S, Desai K, Frizelis F, Khan R, Sjoberg K, Allen P, Manning G, Hendry B, Taylor S, Jones W, Strader M, Bencomo T, Bailey L, Bedolla C, Roldan C, Moudiotis B, Vaidya C, Anning S, Bunce S, Estcourt E, Folland E, Gordon C, Harrill J, Ireland J, Piper L, Scaife K, Sutton S, Wilkins M, Costelloe J, Palmer L, Casas C, Miller M, Burgard C, Erickson J, Hallanger-Johnson P, Clark W, Taylor A, Lafferty S, Gillett C, Nolan M, Pathak L, Sondrol T, Hjelle S, Hafner J, Kotrba R, Hendrickson A, Cemeroglu T, Symington M, Daniel Y, Appiagyei-Dankah D, Postellon M, Racine L, Kleis K, Barnes S, Godwin H, McCullough K, Shaheen G, Buck L, Noel M, Warren S, Weber S, Parker I, Gillespie B, Nelson C, Frost J, Amrhein E, Moreland A, Hayes J, Peggram J, Aisenberg M, Riordan J, Zasa E, Cummings K, Scott T, Pinto A, Mokashi K, McAssey E, Helden P, Hammond L, Dinning S, Rahman S, Ray C, Dimicri S, Guppy H, Nielsen C, Vogel C, Ariza L, Morales Y, Chang R, Gabbay L, Ambrocio L, Manley R, Nemery W, Charlton P, Smith L, Kerr B, Steindel-Kopp M, Alamaguer D, Liljenquist G, Browning T, Coughenour M, Sulk E, Tsalikan M, Tansey J, Cabbage N. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes. Diabetes Care 2019; 42:192-199. [PMID: 30061316 PMCID: PMC6341285 DOI: 10.2337/dc18-0288] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2018] [Accepted: 06/28/2018] [Indexed: 02/03/2023]
Abstract
OBJECTIVE There are variable reports of risk of concordance for progression to islet autoantibodies and type 1 diabetes in identical twins after one twin is diagnosed. We examined development of positive autoantibodies and type 1 diabetes and the effects of genetic factors and common environment on autoantibody positivity in identical twins, nonidentical twins, and full siblings. RESEARCH DESIGN AND METHODS Subjects from the TrialNet Pathway to Prevention Study (N = 48,026) were screened from 2004 to 2015 for islet autoantibodies (GAD antibody [GADA], insulinoma-associated antigen 2 [IA-2A], and autoantibodies against insulin [IAA]). Of these subjects, 17,226 (157 identical twins, 283 nonidentical twins, and 16,786 full siblings) were followed for autoantibody positivity or type 1 diabetes for a median of 2.1 years. RESULTS At screening, identical twins were more likely to have positive GADA, IA-2A, and IAA than nonidentical twins or full siblings (all P < 0.0001). Younger age, male sex, and genetic factors were significant factors for expression of IA-2A, IAA, one or more positive autoantibodies, and two or more positive autoantibodies (all P ≤ 0.03). Initially autoantibody-positive identical twins had a 69% risk of diabetes by 3 years compared with 1.5% for initially autoantibody-negative identical twins. In nonidentical twins, type 1 diabetes risk by 3 years was 72% for initially multiple autoantibody-positive, 13% for single autoantibody-positive, and 0% for initially autoantibody-negative nonidentical twins. Full siblings had a 3-year type 1 diabetes risk of 47% for multiple autoantibody-positive, 12% for single autoantibody-positive, and 0.5% for initially autoantibody-negative subjects. CONCLUSIONS Risk of type 1 diabetes at 3 years is high for initially multiple and single autoantibody-positive identical twins and multiple autoantibody-positive nonidentical twins. Genetic predisposition, age, and male sex are significant risk factors for development of positive autoantibodies in twins.
Collapse
Affiliation(s)
- Taylor M. Triolo
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO
| | - Alexandra Fouts
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO
| | - Laura Pyle
- Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO
| | - Liping Yu
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO
| | - Peter A. Gottlieb
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO
| | - Andrea K. Steck
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Henderson BS, Ice LD, Khaneft D, O'Connor C, Russell R, Schmidt A, Bernauer JC, Kohl M, Akopov N, Alarcon R, Ates O, Avetisyan A, Beck R, Belostotski S, Bessuille J, Brinker F, Calarco JR, Carassiti V, Cisbani E, Ciullo G, Contalbrigo M, De Leo R, Diefenbach J, Donnelly TW, Dow K, Elbakian G, Eversheim PD, Frullani S, Funke C, Gavrilov G, Gläser B, Görrissen N, Hasell DK, Hauschildt J, Hoffmeister P, Holler Y, Ihloff E, Izotov A, Kaiser R, Karyan G, Kelsey J, Kiselev A, Klassen P, Krivshich A, Lehmann I, Lenisa P, Lenz D, Lumsden S, Ma Y, Maas F, Marukyan H, Miklukho O, Milner RG, Movsisyan A, Murray M, Naryshkin Y, Perez Benito R, Perrino R, Redwine RP, Rodríguez Piñeiro D, Rosner G, Schneekloth U, Seitz B, Statera M, Thiel A, Vardanyan H, Veretennikov D, Vidal C, Winnebeck A, Yeganov V. Hard Two-Photon Contribution to Elastic Lepton-Proton Scattering Determined by the OLYMPUS Experiment. Phys Rev Lett 2017; 118:092501. [PMID: 28306315 DOI: 10.1103/physrevlett.118.092501] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2016] [Indexed: 06/06/2023]
Abstract
The OLYMPUS Collaboration reports on a precision measurement of the positron-proton to electron-proton elastic cross section ratio, R_{2γ}, a direct measure of the contribution of hard two-photon exchange to the elastic cross section. In the OLYMPUS measurement, 2.01 GeV electron and positron beams were directed through a hydrogen gas target internal to the DORIS storage ring at DESY. A toroidal magnetic spectrometer instrumented with drift chambers and time-of-flight scintillators detected elastically scattered leptons in coincidence with recoiling protons over a scattering angle range of ≈20° to 80°. The relative luminosity between the two beam species was monitored using tracking telescopes of interleaved gas electron multiplier and multiwire proportional chamber detectors at 12°, as well as symmetric Møller or Bhabha calorimeters at 1.29°. A total integrated luminosity of 4.5 fb^{-1} was collected. In the extraction of R_{2γ}, radiative effects were taken into account using a Monte Carlo generator to simulate the convolutions of internal bremsstrahlung with experiment-specific conditions such as detector acceptance and reconstruction efficiency. The resulting values of R_{2γ}, presented here for a wide range of virtual photon polarization 0.456<ε<0.978, are smaller than some hadronic two-photon exchange calculations predict, but are in reasonable agreement with a subtracted dispersion model and a phenomenological fit to the form factor data.
Collapse
Affiliation(s)
- B S Henderson
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - L D Ice
- Arizona State University, Tempe, Arizona 85281, USA
| | - D Khaneft
- Johannes Gutenberg-Universität, 55099 Mainz, Germany
| | - C O'Connor
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - R Russell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Schmidt
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J C Bernauer
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - M Kohl
- Hampton University, Hampton, Virginia 23668, USA
| | - N Akopov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - R Alarcon
- Arizona State University, Tempe, Arizona 85281, USA
| | - O Ates
- Hampton University, Hampton, Virginia 23668, USA
| | - A Avetisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - R Beck
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - S Belostotski
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - J Bessuille
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - F Brinker
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - J R Calarco
- University of New Hampshire, Durham, New Hampshire 03824, USA
| | - V Carassiti
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, 44122 Ferrara, Italy
| | - E Cisbani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, 00185 Rome, Italy
| | - G Ciullo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, 44122 Ferrara, Italy
| | - M Contalbrigo
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, 44122 Ferrara, Italy
| | - R De Leo
- Istituto Nazionale di Fisica Nucleare sezione di Bari, 70126 Bari, Italy
| | - J Diefenbach
- Hampton University, Hampton, Virginia 23668, USA
| | - T W Donnelly
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - K Dow
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - G Elbakian
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - P D Eversheim
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - S Frullani
- Istituto Nazionale di Fisica Nucleare sezione di Roma and Istituto Superiore di Sanità, 00185 Rome, Italy
| | - Ch Funke
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - G Gavrilov
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - B Gläser
- Johannes Gutenberg-Universität, 55099 Mainz, Germany
| | - N Görrissen
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - D K Hasell
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - J Hauschildt
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - Ph Hoffmeister
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - Y Holler
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - E Ihloff
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Izotov
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - R Kaiser
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - G Karyan
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - J Kelsey
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Kiselev
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - P Klassen
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - A Krivshich
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - I Lehmann
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - P Lenisa
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, 44122 Ferrara, Italy
| | - D Lenz
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - S Lumsden
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Y Ma
- Johannes Gutenberg-Universität, 55099 Mainz, Germany
| | - F Maas
- Johannes Gutenberg-Universität, 55099 Mainz, Germany
| | - H Marukyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - O Miklukho
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - R G Milner
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Movsisyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - M Murray
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - Y Naryshkin
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | | | - R Perrino
- Istituto Nazionale di Fisica Nucleare sezione di Bari, 70126 Bari, Italy
| | - R P Redwine
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | | | - G Rosner
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - U Schneekloth
- Deutsches Elektronen-Synchrotron, 22603 Hamburg, Germany
| | - B Seitz
- University of Glasgow, Glasgow G12 8QQ, United Kingdom
| | - M Statera
- Università degli Studi di Ferrara and Istituto Nazionale di Fisica Nucleare sezione di Ferrara, 44122 Ferrara, Italy
| | - A Thiel
- Rheinische Friedrich-Wilhelms-Universität, 53113 Bonn, Germany
| | - H Vardanyan
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| | - D Veretennikov
- Petersburg Nuclear Physics Institute, Gatchina 188300, Russia
| | - C Vidal
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - A Winnebeck
- Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - V Yeganov
- Alikhanyan National Science Laboratory (Yerevan Physics Institute), 0036 Yerevan, Armenia
| |
Collapse
|
6
|
Platero S, Mokliatchouk O, Jayson GC, Jonker DJ, Rosen LS, Luroe S, Kelsey J, Feltquate D, Velasquez L, Galbraith S. Correlation of FGF2 tumor expression with tumor response, PFS, and changes in plasma pharmacodynamic (PD) markers following treatment with brivanib alaninate, an oral dual inhibitor of VEGFR and FGFR tyrosine kinases. J Clin Oncol 2008. [DOI: 10.1200/jco.2008.26.15_suppl.3506] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
7
|
Hamlyn E, Barrett S, Kelsey J, Lockyer S, Welz T, Poulton M. Improvement in screening for sexually transmitted infections in HIV-positive patients following implementation of a nurse-led clinic. Int J STD AIDS 2007; 18:424-6. [PMID: 17609038 DOI: 10.1258/095646207781024720] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The objective of this study was to assess changes in the uptake of sexually transmitted infection (STI) screening resulting from implementation of a specific STI clinic for HIV-positive patients. An audit of STI screening in HIV-positive patients was undertaken before and after the establishment of the clinic. Significant increases in the number of patients having a sexual health discussion and annual health screen were seen. High rates of positive results were found in all patient groups. National guidelines recommend regular STI screening for all HIV-positive patients. A specific clinic for HIV-positive patients is feasible and acceptable and may result in an increase in uptake of STI screening.
Collapse
Affiliation(s)
- E Hamlyn
- Department of Sexual Health and HIV Medicine, Kings College Hospital, Caldecot Centre, London, UK.
| | | | | | | | | | | |
Collapse
|
8
|
Callahan MB, Lachance JA, Stone RL, Kelsey J, Rice LW, Jazaeri AA. Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer. Am J Obstet Gynecol 2007; 197:199.e1-4; discussion 199.e4-5. [PMID: 17689649 DOI: 10.1016/j.ajog.2007.04.044] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2006] [Revised: 03/13/2007] [Accepted: 04/26/2007] [Indexed: 11/17/2022]
Abstract
OBJECTIVE The purpose of this study was to evaluate the results of substituting cisplatin for carboplatin in women who experienced a carboplatin-associated hypersensitivity reaction while undergoing treatment for gynecologic cancers. STUDY DESIGN Using a comprehensive data repository, we identified all epithelial ovarian cancer and primary peritoneal cancer patients who experienced a documented significant hypersensitivity reaction to carboplatin and were subsequently treated with cisplatin at our institution from 1995 to the present. We also performed a review of published case reports of similar patient management. RESULTS We identified a total of 24 patients who met inclusion criteria. Eighteen patients (75%) tolerated cisplatin without any adverse events. Six patients (25%) eventually developed a reaction to cisplatin; none was life threatening, and only 1 required hospitalization. Twenty-three of the 24 patients (96%) tolerated at least 1 cycle of cisplatin. Of the 5 patients who initially tolerated cisplatin but eventually experienced a reaction, the mean number of cycles tolerated was 3.4. CONCLUSION The use of cisplatin without desensitization is a reasonable approach for continuing platinum-based chemotherapy in patients with a significant carboplatin hypersensitivity reaction. Patients should be advised of risks and closely monitored, given published case reports of anaphylaxis.
Collapse
Affiliation(s)
- Megan B Callahan
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
| | | | | | | | | | | |
Collapse
|
9
|
Dorf E, Kuntz AF, Kelsey J, Holstege CP. Lidocaine-induced altered mental status and seizure after hematoma block. J Emerg Med 2006; 31:251-3. [PMID: 16982355 DOI: 10.1016/j.jemermed.2005.12.021] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2004] [Revised: 07/11/2005] [Accepted: 12/02/2005] [Indexed: 10/24/2022]
Abstract
Hematoma blocks with lidocaine are routinely utilized in the Emergency Department to allow reduction of Colles' fractures. Lidocaine toxicity is a potential complication of this procedure. We present a case report of a patient who developed acute mental status changes and generalized seizure immediately following administration of lidocaine during a hematoma block. The rapid onset of seizure development following injection was most likely due to inadvertent intravascular administration.
Collapse
Affiliation(s)
- Erik Dorf
- Department of Orthopedic Surgery, University of Virginia, Charlottesville, Virginia, USA
| | | | | | | |
Collapse
|
10
|
Arikian S, Casciano J, Kang-Cipolla L, Vodoor M, Grubin M, Clark D, Waugh W, Kelsey J, Osborn LW. The management of depression: the implications for managed care--roundtable discussion: Part 2. Manag Care Interface 2001; Suppl B:19-25, 32. [PMID: 11183021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
One of the most commonly utilized drug classes today is antidepressant therapy, which accounts for billions of dollars in spending. Pharmacoeconomic tools may play an influential role in formulary decision making, particularly in this drug class. In part 2 of the roundtable discussion, a pharmacoeconomic model is presented that may clarify the health economic effects of placing serotonin-norepinephrine reuptake inhibitors on the drug formulary, particularly in the context of other antidepressant medications.
Collapse
|
11
|
Kelsey J, Vodoor M, Hunkeler E, Zarr M, Mason J. The management of depression: the implications for managed care--roundtable discussion: Part 1. Manag Care Interface 2001; Suppl B:12-8. [PMID: 11183020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Depression affects not only the patient and the provider, but the employer as well. Up to 25% of all women experience major depressive disorder, compared with perhaps as many as 12% of all men. It is highly prevalent in patients with other acute and chronic disease. On October 4, 1999, a panel of managed care medical directors, pharmacy directors, clinicians, researchers, and health economists was convened in San Diego to discuss the optimal treatment of the disorder. This roundtable discussion is presented in three parts. The first portion lays the clinical foundation for the management of this critical disorder.
Collapse
|
12
|
Abstract
With the increasing numbers of immigrants coming to the United States from areas where Taeniasis and cysticercosis are endemic, it is important to be familiar with some of these more common entities. We present a patient with both neurologic and soft tissue cysticercosis as well as a review of the available literature.
Collapse
Affiliation(s)
- P Yamashita
- Department of Emergency Medicine, LAC+USC Medical Center, Los Angeles, California 90033, USA
| | | | | |
Collapse
|
13
|
Abstract
OBJECTIVE To compare the association of two measures of physical activity with bone mass in healthy children and young adults, as part of a larger study on bone mineral acquisition in youth. DESIGN Cross-sectional observation study. SETTING General community, outpatient study. PARTICIPANTS Subjects included 103 non-Hispanic white female (n = 54) and male (n = 49) healthy volunteers aged 9 to 25 years. MAIN OUTCOME MEASURES Self-reported physical activity was measured by a 3-day activity diary of all activities and a questionnaire designed to capture recreational activities throughout the year. Activity was expressed as hours per week of weight-bearing and non-weight-bearing activity. Bone mass at the hip, spine, and whole body was measured by dual x-ray absorptiometry. RESULTS The activity measures were not well correlated with each other. In males, weight-bearing and non-weight-bearing activity reported in 3-day diaries was positively associated with bone mass at the hip, spine, and whole body (p < 0.05). Among females, only weight-bearing activity measured by the yearly questionnaires was significantly positively associated with bone mass (p < 0.05). In males and females, weight-bearing activity was more highly correlated with bone mineral than was non-weight-bearing activity. In addition, the associations between activity and bone mass varied by skeletal site. CONCLUSIONS The association between physical activity and bone mass varied both in direction and in significance depending on the physical activity instrument used. Gender differences were observed in the associations between specific activity instruments, type of activity (weight-bearing and non-weight-bearing), and bone mass at different skeletal sites. Variability associated with the two physical activity measures may contribute to discrepant findings in this study and in the literature.
Collapse
Affiliation(s)
- C C Matkin
- Department of Health Research, Stanford University School of Medicine, California 94305-5405, USA
| | | | | | | |
Collapse
|
14
|
Ninan PT, Knight B, Kirk L, Rothbaum BO, Kelsey J, Nemeroff CB. A controlled trial of venlafaxine in trichotillomania: interim phase I results. Psychopharmacol Bull 1998; 34:221-4. [PMID: 9641004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
This article reports the preliminary findings of a two-phase trial examining the efficacy of venlafaxine in trichotillomania. Phase 1 is a 12-week, open-label, prospective trial of venlafaxine in trichotillomania. Venlafaxine was effective in significantly reducing the symptoms of trichotillomania; 8 of 12 patients were considered responders. The implications of the efficacy of venlafaxine in trichotillomania are discussed, including its important advantages over other available antidepressant and anxiolytic medications.
Collapse
Affiliation(s)
- P T Ninan
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
| | | | | | | | | | | |
Collapse
|
15
|
Kelsey J. Francis Glisson 1597-1677. Scalpel Tongs 1997; 41:103-4. [PMID: 11619755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
|
16
|
Abstract
Reptiles are a growing part of the exotic pet trade, and reptile bites have been considered innocuous in the emergency medicine literature. Two cases are reported of reptile bites, one from a green iguana and the other from a reticulated python. The treatment concerns associated with reptile bites are discussed.
Collapse
Affiliation(s)
- J Kelsey
- Department of Emergency Medicine, LAC+USC Medical Center 90033, USA
| | | | | |
Collapse
|
17
|
Abstract
To determine risk factors for ankle and foot fractures, data collected from 9704 women 65 years of age or older from four areas of the United States were analyzed. Self-reported baseline questionnaires covered areas such as lifestyle factors (physical activity, diet, and smoking habits) and functional impairment (history of fracture, falling, and other diseases). Bone mineral density (BMD) and performance on neuromuscular tests were also measured. During 5.9 years of follow-up, 191 women fractured an ankle and 204 women fractured a foot. Proportional hazard models were used to estimate relative risks. In multivariable models, factors associated with ankle fracture included one or more falls in the year prior to baseline (relative risk [RR] 1.5; 95% confidence interval [CI] 1.1-2.1), greater vigorous physical activity (RR per 2 times/week, 1.2; CI 1.1-1.3), weight gain since age 25 (RR per 20% gain, 1.4; CI 1.2-1.5), self-reported osteoarthritis (RR 0.5; CI 0.3-0.8), a sister's history of hip fracture after age 50 (RR 1.7; CI 1.0-3.0), out of house < or = 1 per week (RR 3.0; CI 1.4-6.6), and low distal radius BMD (RR per -0.1 g/cm2, 1.2; CI 1.0-1.4). Factors associated with foot fracture included insulin-dependent diabetes (RR 2.9; CI 1.2-7.2), use of seizure medications (RR 2.3; CI 1.0-5.7) or of benzodiazepines (RR 1.5; CI 1.1-2.2), history of hyperthyroidism (RR 0.5; CI 0.3-1.0), poor far depth perception (RR 0.7; CI 0.5-1.0), and low distal radius BMD (RR per -0.1 g/cm2, 1.3; CI 1.1-1.5). Ankle and foot fractures have different profiles of risk factors that are largely independent of low bone mass.
Collapse
Affiliation(s)
- D G Seeley
- Department of Epidemiology and Biostatistics, University of California, San Francisco, USA
| | | | | | | |
Collapse
|
18
|
Jordan D, McIlvain T, Alarcon R, Beck R, Bertozzi W, Bhushan V, Boeglin W, Chen JP, Dale D, Dodson G, Dolfini S, Dow K, Dzengeleski J, Epstein MB, Farkhondeh M, Gilad S, Görgen J, Holtrop M, Joo K, Kelsey J, Kim W, Laszewski R, Lourie R, Mandeville J, Margaziotis D, Martinez D, Miskimen R, Papanicolas CN, Penn S, Sapp W, Sarty AJ, Tieger D, Tschalaer C, Turchinetz W, Warren G, Weinstein L, Williamson S. Measurement of the longitudinal, transverse, and longitudinal-transverse structure functions in the 2H(e,e'p)n reaction. Phys Rev Lett 1996; 76:1579-1582. [PMID: 10060465 DOI: 10.1103/physrevlett.76.1579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
19
|
Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B. Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev 1995; 4:333-9. [PMID: 7655327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
A series of 3 studies explored the hypothesis that the preponderance of spinal meningiomas among postmenopausal women relates to their higher prevalence of spinal osteoporosis: (a) medical records showed that meningiomas in women, unlike other spinal tumors, usually arise in the mid thoracic spine where osteoporotic vertebral fractures predominate; (b) radiographic evidence of osteoporosis was seen commonly with meningiomas but not with other spinal tumors; and (c) age-adjusted multivariate analysis of data from an interview study of 81 women with spinal meningioma and 155 random digit dial controls showed 6 factors related to risk. Four factors were protective: (a) current use (at diagnosis) of estrogen replacement therapy [odds ratio (OR) = 0.2; 95% confidence interval (CI) = 0.1-0.6]; (b) past use of oral contraceptives (P trend < 0.01); (c) past participation in sports (OR = 0.5; CI = 0.2-0.9); and (d) premenopausal status (OR = 0.2; CI = 0.1-0.7). Risk increased among women who had ever smoked cigarettes (OR = 1.7; CI = 0.9-3.1) or had a history of high dose radiography (> 500 mrad exposure to active marrow/examination; includes upper or lower gastrointestinal series and/or cardiac angiography; OR = 2.9, and CI = 1.6-5.3), although no association was seen with prior radiotherapy. Other results that did not support the hypothesis include findings that cases and controls were similar in mean body weight and in the proportion who had postmenopausal fractures or height loss. In conclusion, these studies lend some support to our hypothesis, but other known meningioma risk factors such as ionizing radiation also appear important.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- S Preston-Martin
- Department of Preventive Medicine, University of Southern California, Los Angeles 90033, USA
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Kelsey J. The global AIDS campaign: Britain's leading role. Nurs J India 1988; 79:259-60. [PMID: 3217265] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
21
|
Lewinnek GE, Kelsey J, White AA, Kreiger NJ. The significance and a comparative analysis of the epidemiology of hip fractures. Clin Orthop Relat Res 1980:35-43. [PMID: 7438622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
A review of the literature on the epidemiology of hip fractures demonstates the predominance of females. Women comprise 70 to 80% of patients with hip fractures. The average age is generally in the eighth decade. Actual incidence rates vary from one study to another, with lower rates among blacks and apparently lower rates from tropical countries. Osteoporosis is more common among patients with hip fractures than in controls and is somewhat more common in intertrochanteric fractures than in femoral neck fractures. Most hip fractures result from comparatively minor falls, such as falls from a bed, a chair, or from a standing position, especially among the elderly. It is estimated that more than 200,000 hip fractures occur each year in the United States, and that the cost of caring for these patients is more than $750,000,000. Approximately 19% of these patients die as a result of the fracture. This contributes significantly to the total number of accidental deaths, which in turn is the fourth largest category in the list of causes of death in the United States.
Collapse
|
22
|
Heath H, Brigden WD, Canever JV, Pollock J, Hunter PR, Kelsey J, Bloom A. Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 1971; 7:308-15. [PMID: 5134253 DOI: 10.1007/bf01219463] [Citation(s) in RCA: 151] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
23
|
Arden GB, Kelsey J. Newer Electrodiagnostic Methods of Assessing Retinal Function [ Abridged]. Proc R Soc Med 1962. [DOI: 10.1177/003591576205500417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|